Low dose methylprednisolone prophylaxis to reduce inflammation during one-lung ventilation

Paediatr Anaesth. 2008 Sep;18(9):857-64. doi: 10.1111/j.1460-9592.2008.02667.x.

Abstract

Background: The specific aim of this study was to examine the efficacy of a low dose of methylprednisolone in minimizing inflammatory response in juvenile piglets when given 45-60 min prior to onset of one-lung ventilation.

Methods: Twenty piglets aged 3 weeks were assigned to either the control group (n = 10) or methylprednisolone group (n = 10). The animals were anesthetized and after 30 min of ventilation, they had their left lung blocked. Ventilation was continued via right lung for 3 h. The left lung was then unblocked. Following another 30 min of bilateral ventilation, the animals were euthanized and both lungs were harvested. The methylprednisolone group had a single dose (2 mg x kg(-1)) of methylprednisolone given i.v. 45-60 min prior to onset of one-lung ventilation. Physiological parameters (PaO2, resistance, and compliance) and markers of inflammation (tumor necrosis factor [TNF]-alpha, interleukin [IL]-1beta, IL-6, and IL-8) were measured at baseline and every 30 min thereafter. Lung tissue homogenates from both collapsed and ventilated lungs were analyzed for TNF-alpha, IL-1beta, IL-6, and IL-8.

Results: The methylprednisolone group had higher partial pressure of oxygen (P = 0.01), lower plasma levels of TNF-alpha (P = 0.03) and IL-6 (P = 0.001) when compared with control group. Lung tissue homogenate in the methylprednisolone group had lower levels of TNF-alpha (P < 0.05), IL-1beta (P < 0.05), and IL-8 (P < 0.05) in both the collapsed and the ventilated lungs.

Conclusions: In a piglet model of one-lung ventilation, use of prophylactic methylprednisolone prior to collapse of the lung improves lung function and decreases systemic pro-inflammatory response. In addition, in the piglets who received methylprednisolone, there were reduced levels of inflammatory mediators in both the collapsed and ventilated lungs.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Anti-Inflammatory Agents / administration & dosage*
  • Biomarkers / blood
  • Blood Gas Monitoring, Transcutaneous
  • Cytokines / blood*
  • Inflammation / blood
  • Inflammation / prevention & control*
  • Interleukins / blood
  • Lung / drug effects
  • Lung / pathology
  • Lung / physiology*
  • Methylprednisolone / administration & dosage*
  • Partial Pressure
  • Random Allocation
  • Respiration, Artificial / adverse effects
  • Respiration, Artificial / methods*
  • Swine
  • Treatment Outcome
  • Tumor Necrosis Factor-alpha / blood

Substances

  • Anti-Inflammatory Agents
  • Biomarkers
  • Cytokines
  • Interleukins
  • Tumor Necrosis Factor-alpha
  • Methylprednisolone